Susquehanna International Group, LLP Rhythm Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$35.41 - $44.37 $594,888 - $745,416	-16,800 Reduced 38.62%	26,700 $1.1 Million
Q1 2024 May 07, 2024	BUY	$39.12 - $52.44 $661,128 - $886,236	16,900 Added 63.53%	43,500 $1.88 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $378,603 - $878,628	17,700 Added 198.88%	26,600 $1.22 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $140,709 - $247,420	8,900 New	8,900 $203,000
Q1 2023 May 16, 2023	BUY	$16.88 - $34.24 $148,544 - $301,312	8,800 Added 22.17%	48,500 $865,000
Q4 2022 Feb 14, 2023	SELL	$22.21 - $30.25 $1.39 Million - $1.89 Million	-62,400 Reduced 61.12%	39,700 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $439,030 - $3.15 Million	102,100 New	102,100 $2.5 Million

178

69.1M

467K

224K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.